Patents by Inventor Seth F. Harris

Seth F. Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminoquinazoline and pyridopyrimidine derivatives
    Patent number: 9855269
    Abstract: The invention provides a method of inhibiting angiogenesis in a patient by administering a compound of formula (I): wherein R1 R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: January 2, 2018
    Assignee: Genentech, Inc.
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Nbdubaku, Lan Wang
  • AMINOQUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES
    Publication number: 20170173026
    Abstract: The invention provides a method of inhibiting angiogenesis in a patient by administering a compound of formula (I): wherein R1 R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: March 9, 2017
    Publication date: June 22, 2017
    Applicant: Genentech, Inc.
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Nbdubaku, Lan Wang
  • Aminoquinazoline and pyridopyrimidine derivatives
    Patent number: 9592235
    Abstract: The invention provides a method of treating cancer in a patient by administering a compound of formula (I): wherein R1 R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: March 14, 2017
    Assignee: Genentech, Inc.
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang
  • AMINOQUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES
    Publication number: 20160296525
    Abstract: The invention provides a method of treating cancer in a patient by administering a compound of formula (I): wherein R1 R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 13, 2016
    Applicant: Genentech, Inc.
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang
  • Aminoquinazoline and pyridopyrimidine derivatives
    Patent number: 9382241
    Abstract: The invention provides novel compounds having the general formula: wherein A, R1, R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Grant
    Filed: May 31, 2013
    Date of Patent: July 5, 2016
    Assignee: Genentech, Inc.
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang
  • AMINOQUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES
    Publication number: 20130324516
    Abstract: The invention provides novel compounds having the general formula: wherein A, R1, R2 and R3 are as defined herein, compositions including the compounds and methods of using the compounds.
    Type: Application
    Filed: May 31, 2013
    Publication date: December 5, 2013
    Inventors: Huifen Chen, Terry Crawford, Seth F. Harris, Steven R. Magnuson, Chudi Ndubaku, Lan Wang